HALO - Halozyme Therapeutics Inc.
IEX Last Trade
63.82
0.080 0.125%
Share volume: 959,677
Last Updated: Fri 30 Aug 2024 09:59:53 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$63.74
0.08
0.13%
Summary score
79%
Profitability
100%
Dept financing
28%
Liquidity
75%
Performance
71%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
47.12%
Return on assets
5.84%
Return on sales
50.13%
Return on invested capital
193.38%
Total debt ratio
86.35%
Debt ratio change over timeo
7.23%
Current Ratio
8.17%
Quick Ratio
7.26%
Cash Position Ratio
4.1%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
56.86%
Return on assets
5.22%
Return on sales
44.07%
Return on invested capital
9.03%
Total debt ratio
91%
Debt ratio change over timeo
9.13%
Current Ratio
6.87%
Quick Ratio
5.7%
Cash Position Ratio
3.42%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
43.21%
Return on assets
5.19%
Return on sales
48.78%
Return on invested capital
9.19%
Total debt ratio
90.34%
Debt ratio change over time
8.25%
Current Ratio
6.64%
Quick Ratio
5.36%
Cash Position Ratio
3.52%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
261.54%
Return on assets
-69.99%
Return on sales
207.91%
Return on invested capital
807.89%
Total debt ratio
722.53%
Debt ratio change over time
7.23%
Current Ratio
51.04%
Quick Ratio
42.49%
Cash Position Ratio
21.67%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HALO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 47.12% | 13.79% | 34.47% | 7.43% |
| Return on assets | 5.84% | 2.76% | 3.15% | 5.62% |
| Return on sales | 50.13% | 28.74% | 32.53% | 40.48% |
| Return on invested capital | 193.38% | 2.36% | 5.39% | 19.77% |
| Profitability | 100% | 34% | 49% | 51% |
| Total debt ratio | 86.35% | 90.46% | 90.54% | 26.74% |
| Debt ratio change over time | 7.23% | 308.97% | -6.99% | 1.18% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 6.87% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.7% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.42% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 7% | 17% | 39% |
| Short-term ratios | HALO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 56.86% | 13.77% | 13.25% | 3.8% |
| Return on assets | 5.22% | 2.43% | 1.89% | 3.09% |
| Return on sales | 44.07% | 24.64% | 23.72% | 30.49% |
| Return on invested capital | 9.03% | 2.14% | 3.39% | 9.18% |
| Profitability | 100% | 37% | 38% | 59% |
| Total debt ratio | 91% | 92.14% | 93.05% | 21.79% |
| Debt ratio change over time | 9.13% | 46.38% | -72.08% | 1.51% |
| Dept financing | 29% | 50% | 25% | 7% |
| Current Ratio | 6.87% | 0.91% | 2.18% | 5.4% |
| Quick Ratio | 5.7% | 0.8% | 1.79% | 4.64% |
| Cash Position Ratio | 3.42% | 0.36% | 1.28% | 2.93% |
| Liquididy | 75% | 9% | 25% | 61% |